When: This event originally occurred on March 18th, 2022.
Presenter: Dr. Fintan Garavan Ph.D., FRCPath (London), MA, BCh., BAO, MB, FNAME
The presentation will use three real case examples to highlight and explain what the main points of interest are when trying to determine if postmortem redistribution is a factor in the interpretation of postmortem toxicology results. The presentation will aim to keep the topic and presentation simple, clear, and concise. The presentation will not be able to cover all aspects of this very broad and complicated subject. However, with the 3 case examples and general background information that will be provided, the expectation is that the audience will have a very good fundamental understanding of how to decide what is and is not relevant and how to work through a case so that a reasonable opinion can be rendered. The importance of understanding the context of any case and why, regardless of where you are in the investigation chain, you must have all the information before you can reasonably provide an interpretation and how the sample site(s) also provide important fundamental information.
Detailed Learning Objectives:
- Understanding the basic premises of postmortem drug redistribution
- The importance of drug sampling and sample site
- To understand the importance of context for any given case
*Funding for this training was made possible by a cooperative agreement between the National Network of Public Health Institutes and the Centers for Disease Control and Prevention [6 NU38OT000303-03-02]. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Centers for Disease Control and Prevention nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Click the Login button below to register for this course!